Chordate Medical Holding AB (osto:CMH PREF) Share Price

Company Profile

Business description
Chordate Medical Holding AB is a medical technology company that has developed patented and CE-marked a new nerve-modulating treatment technology for chronic nasal congestion and chronic migraine. The company sells its products in Selected European markets, Israel, and Saudi Arabia. The company’s product range is based on the CE-marked treatment units Chordate System S100 and S120 for rhinitis and S220 for migraine, registered for the indications of preventive treatment of chronic migraine and chronic rhinitis and use on patients. The company sells its product system, including treatments, through distributors to clinics and hospitals in its primary markets.
Contact
Farogatan 33
164 51 Kista
Kista164 40
SWE
T: +46 840011586
https://www.chordate.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
Employees
3

Recommended

Rising inflation is the fly in the ointment.

Simonelle Mody | 08 January 2026

As we start the new year, let’s take a closer look at three compelling opportunities on the ASX

Tyger Fitzpatrick | 07 January 2026

Shares attractive due to near term profit margin increase and structural growth.

Johannes Faul, CFA | 07 January 2026

Index	Last price	Change	% Change
All Ordinaries	9,046.50	7.00	0.08%
CAC 40	8,243.47	6.04	0.07%
DAX 40	25,127.46	5.20	0.02%
Dow JONES (US)	49,266.11	270.03	0.55%
FTSE 100	10,021.34	26.87	-0.27%
HKSE	26,149.31	561.14	-2.10%
NASDAQ	23,480.02	67.16	-0.29%
Nikkei 225	51,117.26	1,400.82	-2.67%
NZX 50 Index	13,717.80	0.94	0.01%
S&P 500	6,921.46	0.53	0.01%
S&P/ASX 200	8,720.80	2.70	-0.03%
SSE Composite Index	4,082.98	2.79	-0.07%